全文获取类型
收费全文 | 792篇 |
免费 | 57篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 53篇 |
妇产科学 | 13篇 |
基础医学 | 100篇 |
口腔科学 | 31篇 |
临床医学 | 93篇 |
内科学 | 165篇 |
皮肤病学 | 35篇 |
神经病学 | 45篇 |
特种医学 | 134篇 |
外科学 | 60篇 |
综合类 | 37篇 |
预防医学 | 26篇 |
眼科学 | 5篇 |
药学 | 44篇 |
中国医学 | 2篇 |
肿瘤学 | 16篇 |
出版年
2023年 | 4篇 |
2021年 | 12篇 |
2020年 | 13篇 |
2019年 | 18篇 |
2018年 | 11篇 |
2017年 | 17篇 |
2016年 | 18篇 |
2015年 | 23篇 |
2014年 | 26篇 |
2013年 | 34篇 |
2012年 | 17篇 |
2011年 | 11篇 |
2010年 | 47篇 |
2009年 | 39篇 |
2008年 | 15篇 |
2007年 | 28篇 |
2006年 | 16篇 |
2005年 | 19篇 |
2004年 | 11篇 |
2003年 | 13篇 |
2002年 | 12篇 |
2001年 | 8篇 |
2000年 | 14篇 |
1999年 | 13篇 |
1998年 | 44篇 |
1997年 | 38篇 |
1996年 | 36篇 |
1995年 | 23篇 |
1994年 | 33篇 |
1993年 | 29篇 |
1992年 | 9篇 |
1991年 | 13篇 |
1990年 | 7篇 |
1989年 | 24篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 14篇 |
1978年 | 4篇 |
1977年 | 14篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1966年 | 2篇 |
1956年 | 3篇 |
1955年 | 2篇 |
排序方式: 共有864条查询结果,搜索用时 0 毫秒
861.
TALAL AL SAATI SANDRINE GALOIN SYLVIA GRAVEL LAURENCE LAMANT DANIEL RODA SHASHIKANT M. CHITTAL GEORGES DELSOL 《The Journal of pathology》1997,181(4):387-393
Analysis of IgH and TcR-γ genes using consensus primers identifying junctional regions of rearranged genes by polymerase chain reaction (PCR) was performed on tissues involved by Hodgkin's disease (HD) in 90 cases and was correlated with the immunophenotype of Hodgkin and Reed–Sternberg (HRS) cells and the presence of Epstein–Barr virus (EBV) within these cells. Clonal IgH gene rearrangements were found in 1/5 cases of lymphocyte predominance (LP) subtype and none was positive for EBV. In 85 cases of classic HD, no IgH or TcR-γ gene rearrangements were found in 51 (60 per cent) cases. A similar percentage, but not the same cases, were of null (non-B, non-T) phenotype. Of 30 cases where a B phenotype was assigned to HRS cells, nine had IgH gene rearrangements, three had TcR-γ gene rearrangements, and two had both genes rearranged. None of the five cases assigned to T phenotype of HRS cells showed rearrangement of TcR-γ genes, but two cases showed rearranged IgH genes. Among 41 cases of null phenotype, ten had IgH gene rearrangements, five had TcR-γ gene rearrangements, and three cases had both genes rearranged. Whereas EBV was detectable in HRS cells in 17/43 classic HD cases of assigned B phenotype, EBV was also detectable in 2/5 cases of assigned T phenotype and in 21 cases with the null phenotype. Furthermore, there was no correlation of EBV with the presence or lack of IgH or TCR-γ gene rearrangements. Of the remainder, half (30 per cent) expressed antigens associated with lymphocytes without an appropriate genotype. The results confirm lymphocyte-lineage committed cells at the origin of HRS cells in 40 per cent of cases. Any hypothesis of a non-lymphocytic origin of HRS cells will require the inducibility of CD30 on candidate precursors and the methodology for probing genetic events in such cells to be addressed. © 1997 by John Wiley & Sons, Ltd. 相似文献
862.
A mathematical model of intravascular coagulation is presented; it encompasses the biochemistry of the tissue factor pathway, platelet activation and deposition on the subendothelium, and flow- and diffusion-mediated transport of coagulation proteins and platelets. Simulation experiments carried out with the model indicate the predominant role played by the physical processes of platelet deposition and flow-mediated removal of enzymes in inhibiting coagulation in the vicinity of vascular injury. Sufficiently rapid production of factors IXa and Xa by the TF:VIIa complex can overcome this inhibition and lead to formation of significant amounts of the tenase complex on the surface of activated platelets and, as a consequence, to substantial thrombin production. Chemical inhibitors are seen to play almost no (TFPI) or little (AT-III and APC) role in determining whether substantial thrombin production will occur. The role of APC is limited by the necessity for diffusion of thrombin from the site of injury to nearby endothelial cells to form the thrombomodulin-thrombin complex and for diffusion in the reverse direction of the APC made by this complex. TFPI plays an insignificant part in inhibiting the TF:VIIa complex under the conditions studied whether its action involves sequential binding of TFPI to Xa and then TFPI:Xa to TF:VIIa, or direct binding of TFPI to Xa already bound to the TF:VIIa complex. 相似文献
863.
864.